Abstract:Objective: To investigate the relationships between molecular types of the cancer genome atlas (TCGA) of patients with endometrial carcinoma (EC) and lymph node metastasis and other clinicopathological features. Methods: The clinical pathological information of 295 patients with EC who underwent initial inpatient surgical treatment and accepted the detection of the molecular types of TCGA with next-generation sequencing technology at Peking University People's Hospital were collected during April 2016 and May 2022. The TCGA molecular typing of EC was divided into four types: POLE-ultramutated (15 cases), high microsatellite instability (MSI-H; 50 cases), copy-number low (CNL; 175 cases), and copy-number high (CNH; 55 cases). The differences of clinical pathological features among different molecular types and the risk factors of lymph node metastasis were analyzed retrospectively. Results: Among 295 patients with EC, the average age was (56.9±0.6) years. (1) There was a statistically significant difference in lymph node metastasis (0, 8.0%, 10.3% and 25.5%) among the four molecular types (χ2=12.524, P=0.006). There were significant differences in age, stage, pathological type, grade (only endometrioid carcinoma), myometrium invasion, lymphatic vascular space infiltration, and estrogen receptor among the EC patients of four molecular types (all P<0.05). Among them, while in the patients with CNH type, the pathological grade was G3, the pathological type was non-endometrioid carcinoma, and the proportion of myographic infiltration depth ≥1/2 were higher (all P<0.05). (2) Univariate analysis suggested that pathological type, grade, myometrium infiltration depth, cervical interstitial infiltration, lymphatic vascular space infiltration, and progesterone receptor were all factors which significantly influence lymph node metastasis (all P<0.01); multivariate analysis suggested that the lymphatic vascular space infiltration was an independent risk factor for lymph node metastasis (OR=5.884, 95%CI: 1.633-21.211; P=0.007). (3) The factors related to lymph node metastasis were different in patients with different molecular types. In the patients with MSI-H, the non-endometrioid carcinoma of pathological type was independent risk factor for lymph node metastasis (OR=29.010, 95%CI: 2.067-407.173; P=0.012). In the patients with CNL, myometrium infiltration depth≥1/2 (OR=4.995, 95%CI: 1.225-20.376; P=0.025), lymphatic vascular space infiltration (OR=14.577, 95%CI: 3.603-58.968; P<0.001) were the independent risk factors for lymph node metastasis. While in the CNH type patients pathological type of non-endometrioid carcinoma (OR=7.451, 95%CI: 1.127-49.281; P=0.037), cervical interstitial infiltration (OR=22.938, 95%CI: 1.207-436.012; P=0.037), lymphatic vascular space infiltration (OR=9.404, 95%CI: 1.609-54.969; P=0.013), were the independent risk factors for lymph node metastasis. Conclusions: POLE-ultramutated EC patients have the lowest risk of lymph node metastasis, and CNH patients have the highest risk of lymph node metastasis. The risk factors of lymph node metastasis of different molecular types are different. According to preoperative pathological and imaging data, lymph node metastasis is more likely to occur in patients with non-endometrioid carcinoma in MSI-H and CNH type patients, and lymph node metastasis is more likely to occur in patients with myometrium infiltration depth ≥1/2 in CNL type patients.

RISK FACTORS OF PARA-AORTIC LYMPH NODE METASTASIS IN PATIENTS WITH ENDOMETRIAL CARCINOMA

An analysis on the high risk factors of pelvic lymph node metastasis in cervical carcinoma patients

A Clinicopathologic and Prognostic Analysis of 115 Cases of Endometrial Carcinoma

Paraaortic lymph node metastasis in endometrial cancer patients: a comprehensive analysis of rates, survival outcomes, and risk factors through systematic review and meta-analysis

The significance of pelvic lymphadenectomy for stage I endometrial carcinoma.

High-risk factors and prognostic analysis ofpelvic nodal metastasis in patients with endometrial carcinoma

[Analysis of the Risk Factors for Ovarian Metastasis in Patients with Endometrial Carcinoma].

The Characteristics of Isolated Para-Aortic Lymph Node Metastases in Endometrial Cancer and Their Prognostic Significance.

Investigating the Influence of Primary Uterine Tumor Site on Pelvic and Para-Aortic Lymph Node Metastatic Pattern and Evaluating the Risk Factors for Lymph Node Metastases in Endometrial Carcinoma: A Retrospective Study.

[Clinical Analysis on the Lymph Nodes Metastasis Characters and Their Relation with the Prognosis of the Endometrial Carcinoma Patients].

Cervical invasion and lymphovascular space invasion as the most associated risk factors for lymph node metastases in endometrial cancer

Risk factors for paraaortic lymph node metastasis in endometrial cancer

Clinicopathological Risk Factors for Pelvic Lymph Node Metastasis in Clinical Early-Stage Endometrioid Endometrial Adenocarcinoma

Clinical study of the clinical characteristics and prognosis of 1219 cases of endometrial cancer with lymph node metastasis

Risk factors for pelvic and para-aortic lymph node metastasis in non-endometrioid endometrial cancer

[Risk factor analysis of lymph node metastasis in endometrial carcinoma combined with molecular types]

Predictive Factors of Para-Aortic Lymph Nodes Metastasis in Cervical Cancer Patients: a Retrospective Analysis Based on 723 Para-Aortic Lymphadenectomy Cases.

Evaluation of factors influencing lymph node metastasis in endometrial cancers: A retrospective study

Endometriosis in para-aortic lymph node resembling a malignancy: a case report and literature review

Risk factors for pelvic lymph node metastasis in endometrial cancer

Implications of Isolated Para-Aortic Lymph Node Metastasis in Endometrial Cancer: A Large-Scale, Multicenter, and Retrospective Study